|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 47/10 | (2017.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61P 9/04 | (2006.01) |
| (11) | Patento numeris | 3955893 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20720393.6 |
| Europos patento paraiškos padavimo data | 2020-04-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-02-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2020/060523 |
| Data | 2020-04-15 |
| (87) | Numeris | WO 2020/212381 |
| Data | 2020-10-22 |
| (30) | Numeris | Data | Šalis |
| 1904166 | 2019-04-18 | FR |
| (72) |
TEILLAUD, Eric , FR
BAUMARD, Nicolas , FR
RESSEJEAC, Audrey , FR
|
| (73) |
Crossject ,
6 rue Pauline Kergomard
ZAC Parc Mazen Sully, 21000 Dijon,
FR
|
| (54) | SOLUTION PHARMACEUTIQUE D'ADRÉNALINE POUR DISPOSITIF D'INJECTION |
| PHARMACEUTICAL SOLUTION OF ADRENALIN FOR INJECTION DEVICE |